Page 3 - Jaramillo Cardenas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jaramillo cardenas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jaramillo Cardenas Today - Breaking & Trending Today

Alejandra Jaramillo: "¡Valiente!"

Alejandra Jaramillo: "¡Valiente!"
extra.ec - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from extra.ec Daily Mail and Mail on Sunday newspapers.

Marie Emilia , Ephraim Jaramillo , Maria Elena , Presenter Ephraim , Her Force , Related Jaramillo March , Alfonso Spiny , மரியா எலெனா , அவள் படை ,

21st Austria weekly - Valneva, RHI Magnesita (08/03/2021)


14.03.2021
Valneva: Valneva, a specialty vaccine company focused on prevention of diseases with major unmet needs, and Pfizer today announced initiation of study VLA15-221. The VLA15-221 study builds on previous positive Phase 2 studies, incorporates new dose regimens and is anticipated to be the final Phase 2 study readout before a decision to progress into pivotal Phase 3 studies. As announced in December 2020, VLA15-221 is a randomized, observer-blind, placebo-controlled Phase 2 study. It will be the first VLA15 study to include a pediatric population (aged 5-17 years). Overall, the study will enroll approximately 600 healthy participants (aged 5-65 years) who will receive VLA15 or placebo. It will compare the three-dose vaccination schedule (Month 0-2-6) with a two-dose schedule (Month 0-6). Juan Carlos Jaramillo, Chief Medical Officer of Valneva commented, “This trial initiation marks an important step in the development of VLA15 toward a potential licensure. Includin ....

Das Angebot , Juan Carlos Jaramillo , Company Full Year , Chief Medical Officer , Full Year Results , Besuchen Sie , Pic1 Valneva , Vla15 221 , ஜுவான் கார்லோஸ் ஜராமில்லோ , நிறுவனம் முழு ஆண்டு , தலைமை மருத்துவ அதிகாரி , முழு ஆண்டு முடிவுகள் ,